Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab.

Sophie Pereira, Stéphanie Fry + Show 9 more

https://doi.org/10.1111/cea.14392

Copy DOI

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology	Publication Date: Sep 13, 2023
License type: CC BY-NC-ND 4.0

Affiliation: University of Lille, Pasteur Institute of Lille, Inserm, Université de Bretagne Occidentale, Centre Hospitalier Universitaire de Lille, Claude Bernard University Lyon 1, National Polytechnic Institute of Toulouse, University of Strasbourg

#Chronic Obstructive Pulmonary Disease #Chronic Allergic Asthma + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab.

Full Text

Published version (

Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Paper Title

Journal

Date

Author

View more papers

Translate this paper in your preferred language
Listen to the abstract of this paper

Save
Share
Export